THE PERSONAL CARE PRODUCTS COUNCIL for PERSONAL CARE PRODUCTS COUNCIL
What was lobbied
5 issue areas, each in the filer's own words, with who lobbied on it and where.
Consumer Issues/Safety/Products CSP
SHOP SAFE Act (issues related to counterfeit cosmetic products); HR 2269/S 1092, WIPPES Act (product labeling for non-flushable wipes); H.R. 2853 / S. 1404,Combating Organized Retail Crime Act; H.R. 4433, Toxic-Free Beauty Act; H.R. 6832, Packaging and Claims Knowledge (PACK) Act of 2025.
| Lobbyist | Covered position, as disclosed |
|---|---|
| KARIN ROSS | — |
| GENEVIEVE STRAND | — |
Animals ANI
HR 1657, Humane Cosmetics Act; H.R. 2821/S. 355, FDA Modernization Act 3.0 (issues related to animal-based testing for OTC products)
| Lobbyist | Covered position, as disclosed |
|---|---|
| KARIN ROSS | — |
| GENEVIEVE STRAND | — |
Budget/Appropriations BUD
S. 2256, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026 (cosmetic regulation funding issues); H.R. 9747 Continuing Appropriations and Extensions Act of 2025
| Lobbyist | Covered position, as disclosed |
|---|---|
| KARIN ROSS | — |
| GENEVIEVE STRAND | — |
Health Issues HCR
H.R. 4273 / S.2292, Over-the-Counter Monograph User Fees Act (issues related to the OMUFA program); H.R. 3686, Supporting Accessible, Flexible, and Effective (SAFE) Sunscreen Standards Act
| Lobbyist | Covered position, as disclosed |
|---|---|
| KARIN ROSS | — |
| GENEVIEVE STRAND | — |
Tariff (miscellaneous tariff bills) TAR
Section 301, Section 232 and IEEPA Tariffs; USMCA Review
| Lobbyist | Covered position, as disclosed |
|---|---|
| NATALIE OBERMANN | — |
| KARIN ROSS | — |
| GENEVIEVE STRAND | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.